Full Text View
Tabular View
No Study Results Posted
Related Studies
LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00052273   Information provided by Jonsson Comprehensive Cancer Center

First Received on January 24, 2003.   Last Updated on August 2, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adult
Solid Tumor
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
capecitabine
enzastaurin hydrochloride
Additional drug interventions recognized in this trial
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services